Pharmacoepidemiology and Drug Safety

Papers
(The H4-Index of Pharmacoepidemiology and Drug Safety is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Issue Information66
Hepatitis B vaccine and risk of acute myocardial infarction among individuals with diabetes mellitus44
Issue Information44
External validity in distributed data networks39
32
Optimizing therapeutic decision‐making for off‐label medicines use: A scoping review and consensus recommendations for improving practice and research+31
Correction to “Effect of tramadol and DOACs with special attention to dabigatran on concomitant use, on the risk of mayor bleeding using BIFAP database in Spain”30
Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark30
Mixed Impact of Direct Healthcare Professional Communications When Considering Proximal Outcomes and the Targeted Population: A Systematic Review28
Quantitative Benefit–Risk Assessment of Vaccination Against COVID‐19: A Systematic Review27
Linkage of public health and all payer claims data for population‐level opioid research26
Management of epilepsy in Lebanon: Medication reviews and drug‐related problems24
Validation of diagnosis codes for chorioamnionitis in medical encounter data, 2013–201824
Data Resource Profile: The Danish National Hospital Medicine Register24
Comparison of drug prescribing before and during the COVID‐19 pandemic: A cross‐national European study22
Antibiotics and Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome: Analysis of Brazilian Pharmacovigilance Registries22
Validation of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Coding in US Claims Data22
Predicting obesity and smoking using medication data: A machine‐learning approach21
Uncommon side effects of common drugs in patients with familial dysautonomia21
International trends in prescription opioid sales among developed and developing economies, and the impact of the COVID‐19 pandemic: A cross‐sectional analysis of 66 countries21
Issue Information21
0.26329708099365